@article{94d197c429104f2fba7caf0903a31b03,
title = "Thrombosis, Bleeding, and the Promise of Factor XI(a) Inhibition",
keywords = "asundexian, atrial fibrillation, bleeding, stroke, myocardial infarction, placebo, factor XI inhibitor, asundexian, atrial fibrillation, bleeding, stroke, myocardial infarction, placebo, factor XI inhibitor",
author = "Felicita Andreotti and Massimo Massetti and Gilles Montalescot",
year = "2024",
doi = "10.1016/j.jacc.2023.12.003",
language = "English",
volume = "83",
pages = "679--681",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Attuale:ELSEVIER SCIENCE INC, 360 PARK AVE SOUTH, NEW YORK, USA, NY, 10010-1710 W B Saunders Company:Fulfillment Department, The Curtis Center, Independence Square West:Philadelphia, PA 19106:(800)654-2452, (215)238-7800, EMAIL:
[email protected], INTERNET: http://elsevierhealth.com, Fax: (215)238-6445",
}